Reply
Andrew M. Schaefer MRCP
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorRoger Whittaker MRCP
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorRobert McFarland PhD, MRCPCH
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorPatrick F. Chinnery PhD, FRCP
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorRobert W. Taylor PhD, FRCPath
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorDouglass M. Turnbull PhD, FRCP
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorAndrew M. Schaefer MRCP
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorRoger Whittaker MRCP
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorRobert McFarland PhD, MRCPCH
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorPatrick F. Chinnery PhD, FRCP
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorRobert W. Taylor PhD, FRCPath
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this authorDouglass M. Turnbull PhD, FRCP
Mitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for more papers by this author
References
- 1 Schaefer AM, McFarland R, Blakely EL, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008; 63: 35–39.
- 2 Manwaring N, Jones MJ, Wang JJ, et al. Population prevalence of the MELAS A3243G mutation. Mitochondrion 2007; 7: 230–233.
- 3 Elliott HR, Samuels DC, Eden JA, et al. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008; 83: 254–260.
- 4 Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders—past, present and future. Biochim Biophys Acta 2004; 1659: 115–120.
- 5 Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 1997; 120: 1713–1721.
